Impact of Government Assistance, Housing, and Employment on Postpartum Maternal Health Across Income and Race

Stressful periods such as COVID-19, hurricanes or infant formula shortages negatively impact racial groups differently. - December 13, 2024 - Pennington Biomedical Research Center

The Role of Digital Technology in Diabetes Prevention and Management

Scientists at Pennington Biomedical Research Center, along with a colleague from Peking University People’s Hospital in China, have been leading a special collection and published an editorial in Frontiers in Endocrinology, emphasizing the transformative role digital health technologies play... - December 07, 2024 - Pennington Biomedical Research Center

Metabolic and Bariatric Surgery Safe and Effective for Patients with Severe Obesity

A multicenter examination of data demonstrates that for patients with a body mass index at or above 70 kg/m2 metabolic and bariatric surgery is a potent intervention. - December 07, 2024 - Pennington Biomedical Research Center

Dr. Stephanie Waldrop Joins Pennington Biomedical Research Center

New at Pennington Biomedical: Get to Know Dr. Stephanie Waldrop, assistant professor in Clinical Sciences - December 06, 2024 - Pennington Biomedical Research Center

Pennington Biomedical Researchers Share Tips for the Holiday Season

From breakfast to holiday desserts, there are numerous ways to introduce small, manageable changes to your celebration. - November 20, 2024 - Pennington Biomedical Research Center

Let’s Win Pancreatic Cancer Selects TrialX to Launch Its First AI-Powered Global Clinical Trial Finder

Let’s Win Pancreatic Cancer Selects TrialX to Launch Its First AI-Powered Global Clinical Trial Finder

Let’s Win Pancreatic Cancer, a go-to resource that guides patients and caregivers with vital information for better outcomes, launches a new global AI-based clinical trial finder - powered by TrialX - that aims to increase accessibility of clinical trial information for patients and families affected by pancreatic cancer. - November 19, 2024 - TrialX

Rare Disease Foundation on the Road to Gene Therapy Brings Families to Fort Lauderdale from Around the World, November 15-17

Rare Disease Foundation on the Road to Gene Therapy Brings Families to Fort Lauderdale from Around the World, November 15-17

The FOXG1 Research Foundation, the parent-led organization that is radically transforming the rare disease drug development landscape, is hosting an international conference in Fort Lauderdale from November 15-17, bringing families from across the globe together to learn about gene therapy advancements for FOXG1 syndrome. A highlight includes a presentation by 20-year-old Abraham Weitzman, who, though non-speaking, shares his lived experience using an innovative communication device. - November 04, 2024 - FOXG1 Research Foundation

GlycoMira Therapeutics Receives Key Patent for First-in-Class Oncology Therapeutic

GlycoMira Therapeutics Receives Key Patent for First-in-Class Oncology Therapeutic

Key patent covering GlycoMira's lead compound GM-1111 adds to the Company's already strong IP portfolio. - November 04, 2024 - GlycoMira Therapeutics, Inc.

Pennington Biomedical to be on Display at ObesityWeek 2024 in San Antonio

ObesityWeek is home to the latest developments in evidence-based obesity science. - November 02, 2024 - Pennington Biomedical Research Center

Minor Use Foundation Awarded $2M Grant from Assisting Specialty Crop Exports Initiative

Foundation to Support ASCE Project “Increasing Data Generation for Codex and Harmonized MRL Setting” - October 28, 2024 - Minor Use Foundation, Inc.

Zubaidah Nor Hanipah Joins Pennington Biomedical Research Center and the Metamor Institute

Get to Know Dr. Zubaidah "Zuby" Nor Hanipah, professor-research in clinical metabolic surgery. - October 26, 2024 - Pennington Biomedical Research Center

Pennington Biomedical's EAT2 Study to Explore Unknown Effects of Weight Fluctuations

The EAT2 study is recruiting participants now, and participants will be randomly assigned to the two groups - a control group that is weight stable and group with a diet that promotes weight gain. Both groups will participate in a dietary intervention program for 8 weeks, but those in the weight gain group will also be provided with an eight-week weight loss treatment following the dietary intervention. - October 26, 2024 - Pennington Biomedical Research Center

ClinTrial Research (CTR) Welcomes Wendy Tomlinson as the Company’s Chief Operating Officer

ClinTrial Research (CTR) Welcomes Wendy Tomlinson as the Company’s Chief Operating Officer

ClinTrial Research (CTR), proudly welcomes Wendy Tomlinson as the company’s Chief Operating Officer. Tomlinson will oversee activities related to clinical operations, project management, project delivery, and portfolio management. “I am excited for this new chapter and to have the... - October 07, 2024 - ClinTrial Research

Pennington Biomedical Partners on Army-Wide Health and Nutrition Study

Pennington Biomedical’s Center for Military Performance and Resilience and the U.S. Army Research Institute of Environmental Medicine collaborate on study; Louisiana’s Fort Johnson is first installation visit for study. - October 06, 2024 - Pennington Biomedical Research Center

Award-Winning Cleantech Startup Joins Cummings Properties' Woburn, MA Innovation Cluster

Active Surfaces, an early-stage solar technology company, expanded from Greentown Labs' cleantech incubator in Somerville, MA to a dedicated R&D facility in Cummings Properties' Woburn, MA innovation cluster. - October 05, 2024 - Cummings Properties

BÜHLMANN Laboratories AG Announces Worldwide Collaboration with Beckman Coulter for BUHLMANN fCAL® turbo and fPELA® turbo Assays

BÜHLMANN Laboratories AG Announces Worldwide Collaboration with Beckman Coulter for BUHLMANN fCAL® turbo and fPELA® turbo Assays

BÜHLMANN Laboratories AG, a leading manufacturer of specialty, high-quality in-vitro diagnostic and research assays, is pleased to announce the collaboration with Beckman Coulter for a worldwide distribution of the BÜHLMANN fCAL® turbo assay & BÜHLMANN fPELA® turbo assay... - September 26, 2024 - BUHLMANN Diagnostics Corp

SEMA Lab Launches Crowdfunding Campaign for Ultrasound-Enhanced Meditation Retreat

SEMA Lab Launches Crowdfunding Campaign for Ultrasound-Enhanced Meditation Retreat

The Science Enhanced Mindful Awareness (SEMA) Lab, co-directed by Dr. Jay Sanguinetti and world-renowned mindfulness teacher Shinzen Young, has officially launched a crowdfunding campaign to support their latest research endeavor: the world’s first ultrasound-enhanced meditation retreat. - September 13, 2024 - SEMA Lab

Pennington Biomedical’s Greaux Healthy Initiative Takes Aim at Childhood Obesity

Launch coincides with Childhood Obesity Awareness month; Campaign to share Pennington Biomedical research-sourced educational resources with physicians, educators, and families - September 08, 2024 - Pennington Biomedical Research Center

Pennington Biomedical's September Small Shift Focus is Hydration

This month, the Small Shifts Squad at Pennington Biomedical Research Center will focus on something simple yet incredibly impactful: hydrating more. Staying properly hydrated is essential for maintaining energy levels, improving concentration, and supporting overall health. This month, Small... - September 06, 2024 - Pennington Biomedical Research Center

Pennington Biomedical Research Center Adds Director of Intellectual Property and Commercialization

​Reis Alsberry Joins Pennington Biomedical Research Center to lead intellectural property and commercialization efforts. - August 23, 2024 - Pennington Biomedical Research Center

Pennington Biomedical Researcher Dr. Eric Ravussin Joined Experts from Around the World, Agreeing on Fasting Terminology to Boost Global Research

Scientists reach consensus for fasting terminology. - August 11, 2024 - Pennington Biomedical Research Center

Pennington Biomedical Scientists Outline Key Challenges and Promising Avenues in Obesity Genetics

Research article by Pennington Biomedical’s Dr. Sujoy Ghosh and Dr. Claude Bouchard included in the International Journal of Obesity - August 02, 2024 - Pennington Biomedical Research Center

CleverLMS Continues to Improve User Experience by Introducing Offline Mode for Taskhub

CleverLMS is excited to announce the latest enhancement to our platform: the Offline TaskHub feature. This new functionality allows users to continue their workflow seamlessly, even without an internet connection. Report data that employees wish to send is fully saved in a draft if the internet... - July 29, 2024 - CleverLMS

Busch Marine Inc. is Launching a Search Mission for the Wreck of SS I’m Alone

Busch Marine Inc. is Launching a Search Mission for the Wreck of SS I’m Alone

Busch Marine Inc., with locations in Plainwell, Freeland, and Carrollton Michigan, is embarking on a search mission for the wreck of the SS I’m Alone. This deep ocean search will be conducted in the Gulf of Mexico at a depth of 12,000 to 16,000 feet. The SS I’m Alone was a renowned... - July 24, 2024 - Busch Marine Inc.

Pennington Biomedical’s Small Shift for July: Prioritizing Sleep

Small shifts can make a big impact on a person’s long-term health, and that includes catching some Z's. Quality sleep is essential for physical health, mental clarity and emotional resilience. This month, making a few small adjustments to sleep routines can enhance overall health and energy levels. - July 13, 2024 - Pennington Biomedical Research Center

Celebrate National Blueberry Month with Pennington Biomedical

The health benefits of blueberries are believed to be due to the diverse range of phytochemicals they contain, that act as antioxidants, anticancer agents, anti-neurodegenerative agents and anti-inflammatory agents. Because of these properties, many studies have been conducted to evaluate the health benefits of blueberries in chronic disease prevention. - July 10, 2024 - Pennington Biomedical Research Center

Immundiagnostik, Inc. Partners with BioPorto Diagnostics A/S to Expand Renal Research Offering

Immundiagnostik, Inc. Partners with BioPorto Diagnostics A/S to Expand Renal Research Offering

Immundiagnostik, Inc. has partnered with BioPorto Diagnostics A/S to expand its product portfolio to include BioPorto's line of NGAL ELISAs. - July 01, 2024 - Immundiagnostik, Inc.

Cambridge Polymer Group Unveils Restructure to Accelerate Client Innovation through Material Science

Cambridge Polymer Group Unveils Restructure to Accelerate Client Innovation through Material Science

Cambridge Polymer Group (CPG) announced a new leadership structure to better support clients in developing innovative products. CPG is creating a new five-person senior management team with deep materials science expertise, which will allow for closer collaboration with clients on complex projects. Dr. Gavin Braithwaite will be the new CEO and Dr. Stephen Spiegelberg will move to the new role of Chief Scientific Officer (CSO). - June 23, 2024 - Cambridge Polymer Group

Pennington Biomedical Shares Small Shifts for Nutritional Health

As a world-renowned nutrition research center, Pennington Biomedical has been on the forefront of how diet impacts health for decades. With hundreds of studies demonstrating the value of sound nutrition, the research center rolled out its Small Shifts campaign this year to showcase the cumulative value of daily common-sense changes. - June 23, 2024 - Pennington Biomedical Research Center

Simplifying Clinical Trials: TrialX Launches AI powered Clinical Trial Finder for Patient-Friendly Information

Simplifying Clinical Trials: TrialX Launches AI powered Clinical Trial Finder for Patient-Friendly Information

TrialX's new AI powered Clinical Trial Finder tool simplifies access to detailed information on over 58,000 active trials globally. The advanced AI technology transforms complex trial details into clear, concise language, making them understandable for a broader audience. Patients and caregivers can register as volunteers and receive notifications about suitable trials, enhancing participation in clinical research. - June 17, 2024 - TrialX

Groundbreaking Study Shows Promise in AAV9 Gene Therapy for FOXG1 Syndrome; Rescue of Brain Structure Abnormalities and Deficits.

Groundbreaking Study Shows Promise in AAV9 Gene Therapy for FOXG1 Syndrome; Rescue of Brain Structure Abnormalities and Deficits.

New publication shows groundbreaking result in FOXG1 AAV9 gene therapy studies, rescuing structural brain abnormalities caused by the pediatric rare disease, FOXG1 syndrome. This paper summarizing work done by the FOXG1 Research Center, led by Dr. Soo-Kyung Lee, Dr. Jae W. Lee and Dr. Kathrin Meyer (responsible for the SMA gene therapy), shows remarkable rescue of brain abnormalities using AAV9 gene therapy. - June 10, 2024 - FOXG1 Research Foundation

Immundiagnostik, Inc. Launches New and Improved Website

Immundiagnostik, Inc. Launches New and Improved Website

Immundiagnostik, Inc. announces the launch of its new and improved website, making it easier for researchers and clinical lab professionals to find the immunoassays and ELISAs they need. - June 03, 2024 - Immundiagnostik, Inc.

Pennington Biomedical’s Dr. Robert Kesterson Working to Advance Knowledge of Neurofibromatosis Development and Treatment

May is Neurofibromatosis Awareness Month - June 02, 2024 - Pennington Biomedical Research Center

The SELECT Study, Led by Pennington Biomedical Researcher Dr. Donna Ryan, Confirms Weight Loss Benefits of Semaglutide Last up to Four Years

The SELECT Study, led by Pennington Biomedical researcher Dr. Donna Ryan, confirms an average weight reduction of 10 percent compared to a placebo, with results lasting for several years. - May 31, 2024 - Pennington Biomedical Research Center

Pennington Biomedical's Dr. Leanne Redman Talks Changing the Culture: Eating for You, Not for Two

As a world leader in nutrition, LSU’s Pennington Biomedical Research Center scientists have studied prenatal nutrition and discovered eating-for-two is no longer a good mantra for modern moms. - May 19, 2024 - Pennington Biomedical Research Center

Dr. Leanne Redman to Lead Pennington Biomedical’s Nutrition Obesity Research Center

After 19 years, Dr. Eric Ravussin hands baton to Dr. Redman to continue center’s mission of supporting Louisiana’s nutrition and metabolic health research. - May 18, 2024 - Pennington Biomedical Research Center

TaskHub: A CleverLMS Solution for Organizing and Upskilling Workforce

CleverLMS, a tailor-made learning management systems provider, presents TaskHub as a solution to unite the company’s staff management and upskilling. It’s convenient for assigning tasks and work roles, completion tracking, reporting, and surveying. All these operations can be accessed using a single dashboard, so the company’s workflows will be easy to organize without any mess. - May 18, 2024 - CleverLMS

EngWorks Offers Free Trial of ExHAC Hazardous Area Classification Software

EngWorks Offers Free Trial of ExHAC Hazardous Area Classification Software

EngWorks, a leading provider of engineering solutions based in Calgary, Alberta, Canada, is happy to announce an opportunity for professionals to experience the newly released ExHAC Hazardous Area Classification Software with a complimentary two-week trial. The ExHAC software trial provides users... - May 10, 2024 - EngWorks Inc

During Mental Health Awareness Month, Practice Small Shifts for Mental Health and Resilience

May has been designated as Mental Health Awareness Month, and during the month, Pennington Biomedical’s Small Shifts campaign is focuses on mental health and resilience. Giving mental health the attention it deserves is just as important as nurturing physical health. In fact, they’re interdependent. Making small changes to your mental health, like breathing deeply for five minutes, meditating or taking regular breaks from social media, help improve your total wellness. - April 30, 2024 - Pennington Biomedical Research Center

Pennington Biomedical Researcher Dr. Jennifer Caldwell Awarded Pilot Funding for "Linking Genetics and Improving Nutrition in Scotlandville, LA."

Pennington Biomedical Research Center’s Dr. Jennifer Caldwell was named as one of four early-stage investigators to be selected to receive pilot funding of $50,000 from the Forge AHEAD Center, a regional comprehensive research center located at the University of Alabama Birmingham. With a... - April 28, 2024 - Pennington Biomedical Research Center

CleverLMS is Now Empowering the Asian and the Middle Eastern Workforce

The CleverLMS mission is based on educational universality: its features can be easily adapted to the specific business needs of various companies. A 24/7 support center is another key element, available via webchat, email, and phone, resolving all user cases within a maximum of 2.5 hours. CleverLMS works to manage and elevate the most valuable asset of every company: its employees, making businesses more robust, efficient, and resilient. - April 22, 2024 - CleverLMS

Pennington Biomedical’s Dr. Steven Heymsfield and Colleague Publish Guidance on Energy and Macronutrients Across the Lifespan in the NEJM

In the growing campaign positioning “Food as Medicine,” Dr. Steven Heymsfield joins Dr. Sue Shapses of Rutgers University to share a matrix of variables to consider when crafting nutrient-rich diets in the New England Journal of Medicine - April 20, 2024 - Pennington Biomedical Research Center

Pennington Biomedical Researchers Participated in Eight-Year Long GRADE Study on Commonly Used Type 2 Diabetes Medications

Comparative Study of Type 2 Diabetes Medications Shows Differences in Medication Acceptance, Quality-Of-Life, Insulin Secretion and Mortality - March 30, 2024 - Pennington Biomedical Research Center

Pennington Biomedical Shares Health Across the Lifespan Begins with Small Shifts

Small shifts are something that everyone can do and can be incorporated into everyday life. Small shifts add up, and they are reinforcing, which further promotes the activity. - March 22, 2024 - Pennington Biomedical Research Center

A Research Passion for Pennington Biomedical's Dr. Justin Brown

Growing up, Dr. Justin Brown thought his career path would lead him to become a union carpenter in New York City, but when he was 14 years old, his father passed away following a battle with colon cancer. From then on, Dr. Brown’s future career became instantly clear. “My mission is... - March 22, 2024 - Pennington Biomedical Research Center

The University of Iowa Selects TrialX to Build SAYSTOP Study App for a Leading Research Study to Investigate Antibiotics Resistance

The University of Iowa Selects TrialX to Build SAYSTOP Study App for a Leading Research Study to Investigate Antibiotics Resistance

To study a patient-centered approach to antibiotic discontinuation upon symptom resolution in patients with acute uncomplicated pyelonephritis. - March 13, 2024 - TrialX

Pennington Biomedical’s Dr. John Kirwan and Dr. Philip Schauer Among the Key Investigators for the 12-Year Study on the Impact of Bariatric Surgery on Type 2 Diabetes

People with type 2 diabetes who underwent bariatric surgery achieved much better long-term blood glucose control compared to people who received medical management plus lifestyle interventions, according to a new study published in JAMA, or Journal of the American Medical Association, and funded by the National institute of Diabetes, Digestive and Kidney Diseases, part of The National Institutes of Health. - February 29, 2024 - Pennington Biomedical Research Center

New Research Findings Show That Life Span Can be Increased by Making Cells Less Efficient at Producing Energy

Pennington Biomedical Researchers Looking for New Ways to Improve Life Span and Health During Aging - February 23, 2024 - Pennington Biomedical Research Center

New Screening Tool Saving Lives: Metamor Team Developing Tool to Catch Cancer Earlier

A new partnership between a Pennington Biomedical physician-researcher at the Metamor Institute and an LSU School of Medicine oncologist has already saved women’s lives in southeast Louisiana. More than 60,000 women are diagnosed with endometrial cancer each year, a number that includes... - February 22, 2024 - Pennington Biomedical Research Center

Researchers Combine Modern Equipment for Increased Precision in Body Composition Analysis

Pennington Biomedical Professor of Metabolism and Body Composition Dr. Steven Heymsfield is part of a team of researchers who confirm the results in the study: "Generative Deep Learning Furthers the Understanding of Local Distributions of Fat and Muscle on Body Shape and Health Using 3D Surface Scans." - February 21, 2024 - Pennington Biomedical Research Center

Press Releases 1 - 50 of 2,171